- Zacks•26 days ago
CSPC Pharmaceutical (CHPTY) can be an exciting pick in the market as the firm saw robust EPS growth last year, and is looking great for this year too.
- The Wall Street Journal•last month
A federal appeals court threw out a $147 million civil price fixing judgment against Chinese makers of vitamin C, ruling the companies weren’t liable in U.S. courts because they were acting under the direction ...
CSPC PHARMA (1093.HK)
HKSE - HKSE Delayed Price. Currency in HKD
|Day's Range||8.27 - 8.39|
|52wk Range||5.92 - 8.59|
|1y Target Est||N/A|
|P/E Ratio (ttm)||29.56|
|Avg Vol (3m)||10,175,535|
|Dividend & Yield||N/A (N/A)|